federal_register: 94-6292
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 94-6292 | Drug Export; Serzone (Nefazodone HCl) Tablets 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg | Uncategorized Document | The Food and Drug Administration (FDA) is announcing that Bristol-Myers Squibb has filed an application requesting approval for the export of the human drug Serzone (nefazodone HCl) 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg Tablets to Canada. | 1994-03-18 | 1994 | 3 | https://www.federalregister.gov/documents/1994/03/18/94-6292/drug-export-serzone-nefazodone-hcl-tablets-50-mg-100-mg-150-mg-200-mg-and-300-mg | Health and Human Services Department | 221 | The Food and Drug Administration (FDA) is announcing that Bristol-Myers Squibb has filed an application requesting approval for the export of the human drug Serzone (nefazodone HCl) 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg Tablets to Canada. |